The Population Research Core (PopRC) is a new shared resource for the HCCC. The Population Research Core is designed to assist HCCC members in conducting the highest quality genetic, epidemiologic, behavioral, applied, and surveillance cancer research based on enhancing access to, and connection between, large population databases. Its basic function is to serve as a resource to HCCC investigators who want to extend research findings to specific populations and who want to explore other population-based research questions. More specifically, the Population Research Core provides access for HCCC to: ? lowa Cancer Registry surveillance data ? lowa and SEER tissue repositories ? lowa mortality database ? lowa voter registration database ? lowa driver's license database ? SEER-Medicare database ? lowa Medicaid Database ? Cancer Care Outcomes Research &Surveillance Consortium ? Health Effectiveness Research Center ? Agricultural Health Study ? Center for the Heatth Effects of Environmental Contamination ? lowa Cancer Consortium The Population Research Core includes staff based in institutional centers of expertise, with intimate knowledge of the resources of these centers and how to harness them. Despite being a new shared research resource, in 2009, the Population Research Core provided services to 18 HCCC members with peer reviewed funding including investigators who are members of all 6 programs.

Public Health Relevance

The ability to analyze large population-based databases, and equally importantly, link them to each other, is vital for many cancer researchers. The Population Research Core provides access to such data to cancer researchers, and also provides the expertise needed to utilize this data which would, otherwise, not be available.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-13
Application #
8466225
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
13
Fiscal Year
2013
Total Cost
$86,742
Indirect Cost
$31,206
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Vijapura, Charmi; Yang, Limin; Xiong, Jinhu et al. (2018) Imaging Features of Nonmalignant and Malignant Architectural Distortion Detected by Tomosynthesis. AJR Am J Roentgenol 211:1397-1404
Brooks, Nathan A; Boland, Riley S; Strigenz, Michael E et al. (2018) Nongenitourinary complications associated with robot-assisted laparoscopic and radical retropubic prostatectomy: A single institution assessment of 1,100 patients over 11 years. Urol Oncol 36:501.e9-501.e13
Sandgren, Jeremy A; Deng, Guorui; Linggonegoro, Danny W et al. (2018) Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice. JCI Insight 3:
Jiang, Cheng-Fei; Shi, Zhu-Mei; Li, Dong-Mei et al. (2018) Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer. Mol Cancer 17:83
Moss, Jennifer L; Xiao, Qian; Matthews, Charles E (2018) Patterns of cancer-related health behaviors among middle-aged and older adults: Individual- and area-level socioeconomic disparities. Prev Med 115:31-38
Monga, Varun; Maliske, Seth M; Kaleem, Hassan et al. (2018) Discrepancy between treatment goals documentation by oncologists and their understanding among cancer patients under active treatment with chemotherapy. Eur J Cancer Care (Engl) :e12973
Swami, Umang; Lenert, Petar; Furqan, Muhammad et al. (2018) Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities? J Thorac Oncol 13:e102-e103
Seaman, Aaron T; Dukes, Kimberly; Hoffman, Richard M et al. (2018) The complicated 'Yes': Decision-making processes and receptivity to lung cancer screening among head and neck cancer survivors. Patient Educ Couns 101:1741-1747
Shields, Anthony F; Jacobs, Paula M; Sznol, Mario et al. (2018) Immune Modulation Therapy and Imaging: Workshop Report. J Nucl Med 59:410-417
Alexander, Matthew S; Wilkes, Justin G; Schroeder, Samuel R et al. (2018) Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer. Cancer Res 78:6838-6851

Showing the most recent 10 out of 1080 publications